In the context of the COVID-19 pandemic and the ongoing vaccination efforts, it is essential for Seppic to be present at the World Vaccine Congress Europe, the European biggest vaccine meeting gathering experts across the world to discuss all the hot topics of the vaccination with a specific focus on COVID-19. Major national and international institutions such as WHO, CEPI and the European Commission, which play a key role in the development and commercialisation of vaccines, will also be attending.
An occasion for Seppic to present Sepivac SWE™, a ready-to-use squalene-based adjuvant available on open access and at GMP grade, designed for prophylactic vaccines. It’s being used in covid-19 vaccine candidates under clinical evaluation !
At booth 39, Juliette Ben Arous, Hocine Nouari and Aurélie Bouillet, will be happy to further discuss with you about Sepivac SWE™!
And do not miss VIDO’s conference on Wednesday 20th October 2021 at 11:45 on COVAC-2: a S1 subunit-based COVID-19 vaccine adjuvanted with Sepivac SWE™ by Dr Trina Racine, Associate Director, Vaccine Development.